TH134254B - Sodium 1H-pyrazol-5-olate is replaced (Substituted sodium 1H-pyrazol-5-olate). - Google Patents
Sodium 1H-pyrazol-5-olate is replaced (Substituted sodium 1H-pyrazol-5-olate).Info
- Publication number
- TH134254B TH134254B TH1301002627A TH1301002627A TH134254B TH 134254 B TH134254 B TH 134254B TH 1301002627 A TH1301002627 A TH 1301002627A TH 1301002627 A TH1301002627 A TH 1301002627A TH 134254 B TH134254 B TH 134254B
- Authority
- TH
- Thailand
- Prior art keywords
- olate
- pyrazol
- sodium
- replaced
- substituted
- Prior art date
Links
- 229910052708 sodium Inorganic materials 0.000 title claims abstract 4
- 239000011734 sodium Substances 0.000 title claims abstract 4
- XBYRMPXUBGMOJC-UHFFFAOYSA-M 1H-pyrazol-5-olate Chemical compound [O-]C1=CC=NN1 XBYRMPXUBGMOJC-UHFFFAOYSA-M 0.000 title claims abstract 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 title claims abstract 3
- -1 sodium 1H-pyrazol-5-olate Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000000875 corresponding Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 208000008787 Cardiovascular Disease Diseases 0.000 abstract 1
- 208000005209 Hematologic Disease Diseases 0.000 abstract 1
- 208000001083 Kidney Disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drugs Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001737 promoting Effects 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Abstract
คำยื่นขอครั้งนี้ จะเกี่ยวข้องกับ โซเดียม 1-[6-(เมอร์โฟลิน-4-อิล)ไพริมิดิน-4-อิล]-4- (1H-1,2,3-ไดรอะโซล-1-อิล)1H-ไพราโซล-5-โอเลท(Sodium1-[6-(morpholin-4- y1](1H-1,2,3-triazol-1-y1)-1H-pyrazol-5-olate)กับกระบวนการสำหรับการจัดเตรียมมัน กับ การใช้มันสำหรับการรักษา เเละ/หรือ การป้องกันของโรค เเละ กับการใช้มันสำหรับการจัดเตรียม ตัวยารักษาสำหรับการรักษา เเละ/หรือ การป้องกันของโรค โดยเฉพาะ หัวใจร่วมหลอดเลือด เเละ โรคทางโลหิตวิทยา เเละโรคไต เเละสำหรับการส่งเสริมการสมานบาดเเผล This application It is associated with sodium 1- [6- (murfolin-4-il) pyrimidin-4-il] -4- (1H-1,2,3-driazole-1. - il) 1H-pyrazol-5-olate (Sodium1- (6- (morpholin-4- y1) (1H-1,2,3-triazol-1-y1) -1H-pyrazol-5-olate ) With the process for preparing it, and using it for treatment and / or prevention of disease, and using it for preparation. Medicines for the treatment and / or prevention of disease, especially cardiovascular and hematological diseases and kidney disease, and for promoting wound healing.
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH134254B true TH134254B (en) | 2014-06-03 |
| TH134254A TH134254A (en) | 2014-06-03 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017127135A (en) | THERAPEUTICALLY AGAINST CANCER OF CANCER | |
| EA200970674A1 (en) | AMID-SUBSTITUTED INDASOLES AS POLY INHIBITORS (ADP-RYBOSE) POLYMERASE (PARP) INHIBITORS | |
| EA201270575A1 (en) | CONNECTIONS | |
| CY1120375T1 (en) | SUBSTITUTED 1H-PYRAZOLO-5-TOTAL Sodium | |
| EA201071144A1 (en) | HETEROCYCLIC DERIVATIVES | |
| BR112015001608A2 (en) | lfa-1 inhibitor and polymorph thereof | |
| EA201200318A1 (en) | Heterocyclic oximes | |
| BR112015016446A2 (en) | Process for the preparation of the compounds of formula and a triazole compound of formula, aqueous solution, use of aqueous solution, crystalline form, agrochemical composition, use of crystalline forms and method for combating harmful fungi | |
| BR112014007163A2 (en) | n-methyl-2 [3 ((e) -2-pyridin-2-yl-vinyl) -1h-indazol-6-ylsulfanyl] -benzamide pharmaceutical compositions | |
| EA201170521A1 (en) | NEW CONNECTIONS | |
| NZ596882A (en) | Disubstituted phthalazine hedgehog pathway antagonists | |
| EA201300250A1 (en) | OXADIAZOL INHIBITORS OF LEUKOTRIEN PRODUCTION | |
| EA201100254A1 (en) | NEW CONNECTIONS | |
| CY1118818T1 (en) | 1- [1- (BENZOYL) -PYRROLIDINO-2-CARBONYL] -PYRROLIDINO-2-CARBONYL | |
| IN2012DN00953A (en) | ||
| EA201100696A1 (en) | 1- (ARILSULPHONIL) -4- (PIPERAZIN-1-IL) -1H-BENZIMIDAZOLES AS 5-HYDROXITRIPTAMINE-6 LIGANDS | |
| RU2018119102A (en) | THERAPEUTIC FOR TREATMENT OF BREAST CANCER | |
| NZ705813A (en) | Treatment of mild and moderate alzheimer’s disease | |
| EA201001427A1 (en) | TIAZOLIDIGIDROIDAZOLE | |
| CL2014003003A1 (en) | Process for the preparation of 1- [6- (morpholin-4-yl) pyrimidin-4-yl] -4- (1h-1,2,3-triazol-1-yl) -1h-pyrazole-5-ol ( i - enol form) or 2- [6- (morpholin-4-yl) pyrimidin-4-yl] -4- (1h-1,2,3-triazol-1-yl) -1,2-dihydro- 3h-pyrazol-3-one (i-keto form); and intermediate compound (2e / z) -3- (dimethylamino) -2- (1h-1,2,3-triazol-1-yl) methyl acrylate. | |
| EA201170736A1 (en) | SYNTHESIS AND NEW SALT SHAPES | |
| TH134254B (en) | Sodium 1H-pyrazol-5-olate is replaced (Substituted sodium 1H-pyrazol-5-olate). | |
| BR112015003281A2 (en) | diazepinone derivatives useful for the treatment of fragile x syndrome, parkinson's disease or reflux | |
| TH134254A (en) | Sodium 1H-pyrazol-5-olate is replaced (Substituted sodium 1H-pyrazol-5-olate). | |
| EA201201049A1 (en) | 5-ALKINILPYRIMIDINES AND THEIR APPLICATION AS KINASE INHIBITORS |